KR20090097069A - Composition of Volatile Liquid Tobacco Nicotine - Google Patents
Composition of Volatile Liquid Tobacco Nicotine Download PDFInfo
- Publication number
- KR20090097069A KR20090097069A KR1020080022695A KR20080022695A KR20090097069A KR 20090097069 A KR20090097069 A KR 20090097069A KR 1020080022695 A KR1020080022695 A KR 1020080022695A KR 20080022695 A KR20080022695 A KR 20080022695A KR 20090097069 A KR20090097069 A KR 20090097069A
- Authority
- KR
- South Korea
- Prior art keywords
- tobacco
- nicotine
- flavor
- smoke
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 59
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title claims abstract description 56
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title claims abstract description 56
- 229960002715 nicotine Drugs 0.000 title claims abstract description 56
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 239000007788 liquid Substances 0.000 title claims abstract description 29
- 244000061176 Nicotiana tabacum Species 0.000 title claims 4
- 239000000779 smoke Substances 0.000 claims abstract description 37
- 235000019504 cigarettes Nutrition 0.000 claims abstract description 14
- 239000000796 flavoring agent Substances 0.000 claims abstract description 13
- 235000019634 flavors Nutrition 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 8
- 229940069445 licorice extract Drugs 0.000 claims abstract description 6
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 5
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 5
- 229940038487 grape extract Drugs 0.000 claims abstract description 5
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 5
- 229940094952 green tea extract Drugs 0.000 claims abstract description 5
- 229940041616 menthol Drugs 0.000 claims abstract description 5
- 239000008370 chocolate flavor Substances 0.000 claims abstract description 4
- 235000019506 cigar Nutrition 0.000 claims abstract description 4
- 239000008373 coffee flavor Substances 0.000 claims abstract description 4
- 239000008369 fruit flavor Substances 0.000 claims abstract description 4
- 239000002023 wood Substances 0.000 claims description 8
- 239000000052 vinegar Substances 0.000 claims description 7
- 235000021419 vinegar Nutrition 0.000 claims description 7
- 241000196324 Embryophyta Species 0.000 claims description 6
- 239000007967 peppermint flavor Substances 0.000 claims description 4
- 244000061408 Eugenia caryophyllata Species 0.000 claims 1
- 241000208125 Nicotiana Species 0.000 abstract description 55
- 230000000391 smoking effect Effects 0.000 abstract description 16
- 231100000357 carcinogen Toxicity 0.000 abstract description 8
- 239000003183 carcinogenic agent Substances 0.000 abstract description 8
- 239000003440 toxic substance Substances 0.000 abstract description 6
- 244000223014 Syzygium aromaticum Species 0.000 abstract description 4
- 231100000481 chemical toxicant Toxicity 0.000 abstract description 4
- 208000023504 respiratory system disease Diseases 0.000 abstract description 4
- 244000246386 Mentha pulegium Species 0.000 abstract 1
- 235000016257 Mentha pulegium Nutrition 0.000 abstract 1
- 235000004357 Mentha x piperita Nutrition 0.000 abstract 1
- 235000001050 hortel pimenta Nutrition 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 3
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- 208000018737 Parkinson disease Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 208000028017 Psychotic disease Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 201000000980 schizophrenia Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 235000002918 Fraxinus excelsior Nutrition 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 206010023825 Laryngeal cancer Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- -1 acetic acid Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000002956 ash Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010023841 laryngeal neoplasm Diseases 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940055329 tobacco leaf extract Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/243—Nicotine
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Manufacture Of Tobacco Products (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 휘발성 액상담배 니코틴의 조성물에 관한 것으로서 통상의 궐련형 담배의 대체 담배로서 흡연자가 담배를 흡연시 궐련형 잎담배에 불을 붙여서 잎담배를 태우면 연기의 발생으로 인한 주변의 부류연으로 인한 간접흡연, 냄새의 발생, 담배연기 속에 4,000여종이나 되는 발암물질과 독성화학물질로 특히 20여종의 A급 발암물질로 인한 호흡기질환, 담뱃불로 인한 화재 등등의 문제점을 개선한 휘발성 액상담배 니코틴의 조성물로서 식물에서 추출한 순수한 니코틴 액과 참나무에서 추출한 목초액, 감초추출물, 녹차추출물, 포도추출물, 정향추출물, 에탄올, 박하향(멘톨), (또는 초코향, 커피향, 허브향, 과일향, 한약제향, 시가잎 담배향 )등을 첨가하여 조성한 액상담배 니코틴의 조성물로서 휘발되는 냄새를 코로 흡입하여 흡연의 욕구를 만족하게 하는 액상의 휘발성 액상담배 니코틴의 특징으로서 연기의 발생이 전혀 없기 때문에 주변의 간접흡연에 영향이 전혀 없으며, 담배연기로 인한 4,000여가지의 발암물질과, 독성화학물질로 인한 각종의 호흡기 질환으로부터 좀 더 안전한 흡연의 대용품인 것에 그 특징이 있다.The present invention relates to a composition of volatile liquid tobacco nicotine as an alternative to a conventional cigarette type cigarette smoker smokes the tobacco leaf tobacco when smoking the tobacco leaf smoke indirect smoking due to the side smoke caused by the generation of smoke It is a composition of volatile liquid tobacco nicotine that improves the problem of odor occurrence, 4,000 kinds of carcinogens and toxic chemicals in tobacco smoke, especially respiratory diseases caused by 20 kinds of Class A carcinogens, fire due to cigarettes, etc. Extracted pure nicotine liquid, oak extract from oak, licorice extract, green tea extract, grape extract, cloves extract, ethanol, peppermint (menthol), (or chocolate flavor, coffee flavor, herb flavor, fruit flavor, herbal flavor, cigar leaf tobacco flavor It is a liquid tobacco nicotine composition which is added with) to satisfy the desire of smoking by inhaling the volatilized odor through the nose. As a characteristic of volatile liquid tobacco nicotine, it does not generate any smoke, so there is no influence on the surrounding indirect smoking, and it can be prevented from 4,000 kinds of carcinogens caused by tobacco smoke and various respiratory diseases caused by toxic chemicals. It is characterized by being a safer substitute for smoking.
Description
본 발명은 휘발성 액상담배 니코틴의 조성물에 관한 것으로서, 상세히 설명하면 다음과 같다.The present invention relates to a composition of volatile liquid tobacco nicotine, which will be described in detail as follows.
본 발명은 통상의 궐련형 잎담배의 대체 담배로서 흡연자가 궐련형 잎담배에 불을 붙여서 잎담배를 태우면 연기의 발생으로 담배 연기속에 4,000여 가지의 발암물질 및 독성화학물질이 흡연자 및 비흡연자에게 각종의 질병 및 호흡기질환을 발생시키고, 화재발생 등 이러한 문제점을 해소하고자 본 발명의 기술분야는 식물에서 추출한 니코틴, 목제에서 추출한 정제목초액, 녹차추출물, 박하향(멘톨), 에탄올, 감초추출물, 포도추출물, 정향추출물, 허브향등을 첨가하여 휘발성 액상담배 니코틴의 조성물을 합성하여 코로 휘발되는 냄새를 들여 마시기 위한 휘발성 액상담배 니코틴의 조성물에 그 특징이 있다.The present invention is an alternative to the conventional tobacco leaf tobacco cigarettes smoker fires the tobacco leaf tobacco smokes the leaf tobacco by the generation of smoke 4,000 kinds of carcinogens and toxic chemicals in tobacco smoke to smokers and non-smokers various diseases In order to solve the problems such as the occurrence of respiratory diseases and fire, the technical field of the present invention is nicotine extracted from plants, purified wood vinegar extracted from wood, green tea extract, peppermint flavor (menthol), ethanol, licorice extract, grape extract, cloves extract It is characterized by the composition of volatile liquid tobacco nicotine for adding a herb flavor and the like to synthesize the composition of volatile liquid tobacco nicotine and breathe in the smell of volatilized nose.
본 발명은 휘발성 액상담배 니코틴의 조성물에 관한 것으로서, 통상의 흡연자를 위한 담배유형으로서 궐련형 잎담배, 니코틴함유 껌 담배, 담배원료를 태워서 발생되는 연기를 물에 통과 시켜 발생되는 수증기를 입으로 흡입하는 물담배, 담배의 분말원료를 코로 강하게 흡입하는 코담배 등으로서, 본 발명은 식물 에서 추출 한 니코틴액에 정제목초액, 감초추출물, 허브향 물질을 첨가하여 휘발 되는 휘발물질을 코로 흡입하고자 하는 것에 그 특징이 있는 것이다.The present invention relates to a composition of volatile liquid tobacco nicotine, which is a cigarette type for a typical smoker, which inhales the vapor generated by passing smoke generated by burning tobacco leaf tobacco, nicotine-containing gum tobacco, and tobacco raw materials through water. As a snuff, which strongly inhales nasal tobacco and powdered powder of tobacco into the nose, the present invention is intended to inhale a volatilized substance into the nose by adding purified wood vinegar licorice, licorice extract, and herbal flavor to the nicotine liquid extracted from plants. There is this.
본 발명은 휘발성 액상담배 니코틴의 조성물에 관한 것으로서, 상세하게 설명하면 다음과 같다.The present invention relates to a composition of volatile liquid tobacco nicotine, which will be described in detail as follows.
흡연으로 인하여 흡연자 본인은 물론 주변에 간접흡연으로 인한 피해가 더욱 심각하여 금연장소를 정하여 흡연을 규제하고 있다 간접흡연의 심각성을 인식한 미국의 보건성에서 발표한 간접흡연의 피해에 대하여 전세계에 발표된 연구보고서에 의하면 간접흡연은 비흡연자에게도 폐암을 비롯한 질병의 원인이 된다는 것과 흡연자들 가정에 아이들에게도 감염이나 증상의 빈도가 증가하는 동시에 폐기능 증가속도가 더디다는 점, 비흡연자가 흡연자의 담배연기를 들여 마시는 경우는 그 연기가 어디서 오는 것이냐에 따라 주류담배연기(mainstream smoke) 흡입과 비주류 담배연기(sidestream smoke) 흡입 등 두 가지로 구분한다. 주류담배연기란 흡연자가 직접 흡입한 담배연기가 일단 흡연자의 폐 속에서 여과된 뒤에 밖으로 내뿜어지는 연기를 말하며, 비주류 담배연기란 흡연자가 들고 있는 담배자체가 타 들어 가면서 공기중에 직접 확산되는 연기를 말한다. 실내에 흡연하는 사람이 있는 경우 그 실내 공기중에 섞이는 담배연기 가운데는 75％내지 85％가 비주류 담배연기인데 이 비주류 담배연기는 대체로 곧장 공기중에 회석이 되기 때문에 그 농도가 비교적 적긴 하지만 연기중의 성분에 있어서는 주류 담배연기보다 훨씬 인체에 해로운 것이 많 다. 흡연으로 인해 실내에서 증가하게 되는 유해 기체성분은 일산화탄소, 탄산가스, 이산화질소, 암모니아, 메탄, 아세틸렌, 등이며 미립자 성분으로는 타르, 니코틴, 수분, 톨루엔, 페놀, 아닐린 등이 있는데 비주류 담배연기에서 주류담배연기 보다 이들 인체에 유해한 기체나 미립자 성분이 더 증가하기 때문이다. (연세대학교 예방의학교실 논문)이에 있어서 휘발성 액상담배니코틴의 조성물은 도면제1도 3의 용기에 휘발성 액상담배 니코틴의 조성물을 넣어서 도면제1도 2의 다공성 스폰지를 통하여 휘발되는 냄새를 코로 맡도록 하여 간접흡연의 문제를 해결하였다.Smoking is more severe than the smokers themselves and the surrounding area. The smoking area is regulated by setting smoking cessation areas. The US Department of Health recognizes the seriousness of secondhand smoke. According to research reports, second-hand smoke is a cause of diseases such as lung cancer in nonsmokers, children in smokers' families have a higher frequency of infections and symptoms, and a slower rate of lung function increase. There are two ways to inhale smoke, depending on where it comes from: inhaling mainstream smoke and inhaling sidestream smoke. Mainstream tobacco smoke refers to the smoke emitted by a smoker directly after it is filtered through the smoker's lungs, and non-mainstream tobacco smoke refers to the smoke that is directly diffused into the air as the cigarette itself is burning. . If there is a person who smokes indoors, 75% to 85% of the cigarette smoke mixed in the indoor air is non-mainstream tobacco smoke. The non-mainstream tobacco smoke is relatively straight, and its concentration is relatively low. There is much more to human health than mainstream tobacco smoke. The harmful gaseous components that are increased indoors due to smoking are carbon monoxide, carbon dioxide, nitrogen dioxide, ammonia, methane, acetylene, etc.The particulate components include tar, nicotine, moisture, toluene, phenol, and aniline. This is because there are more gas or particulate components that are more harmful to the human body than tobacco smoke. (Thesis of Yonsei University Preventive Medicine) The composition of volatile liquid tobacco nicotine in the container of Figure 1 Figure 3 to put a composition of volatile liquid tobacco nicotine to smell the volatilization through the porous sponge of Figure 1 Figure 2 This solved the problem of indirect smoking.
본 발명의 휘발성 액상담배 니코틴의 조성물의 효과에 대하여 보다 구체적으로 설명 하면 다음과 같다.When explaining the effect of the composition of the volatile liquid tobacco nicotine of the present invention in more detail.
이러한 흡연으로 인한 연기의 발생으로 간접흡연의 문제점을 근본적으로 해결하기 위하여 연기의 발생이 없는 휘발성 액상담배 니코틴의 조성물로서 도면 제1도 의 3용기에 본 조성물을 넣어서 흡연자가 흡연 욕구시 도면 제1도 1의 뚜껑을 열어서 코로 휘발되는 니코틴의 조성물의 냄새를 맡도록 하였다.In order to fundamentally solve the problem of indirect smoking due to the generation of smoke caused by smoking, a composition of volatile liquid tobacco nicotine without the generation of smoke is shown in FIG. The lid of Figure 1 was opened to sniff the composition of nicotine volatilized into the nose.
휘발되는 니코틴은 연기의 발생이 없으므로 간접흡연의 피해가 없고 흡연자에게도 연기의 발생으로 직접흡연자가 흡연시 들이마시는 주류연에 포함된 발암물질과 독성물질 4천 여종이 포함되어 있는데 인체에 치명적인 피해를 미치는 연기를 입으로 들여 마시지 않으므로 호흡기질병, 후두암, 구강암 등의 질병으로부터 보다 더 안전 할 수가 있는데 그 특징이 있는 휘발성 액상담배 니코틴의 조성물 인터넷과학신문 사이언스타임즈에 의하면 담배 속 유해물질인 니코틴과 몸속에서 반응하는 단백질의 메커니즘을 처음으로 규명한 내용을 보면 세계적인 과학저널인 네이처 에 게재된 이번연구는 니코틴성 아세틸콜린 수용체가 어떻게 신경전달물질 결합부분과 연결되는지를 밝혀 향후 치료제 개발에도 유용할 것으로도 기대한다고 하였고 메커니즘을 규명한 니코틴성 아세틸콜린 수용체는 사람의 근육이나 중추신경, 면역세포 등에 주로 분포하여 담배 추출물인 니코틴과 결합을 잘하는 특징 때문에 니코틴성 이라는 이름이 붙었고 연구팀은 이번 연구에서 사람 근육에 분포하는 니코틴성 아세틸콜린 수용체의 유전자를 조작하는 방법으로 이온채널과 가까운 부분의 구조를 변경한 다음 니코틴성 아세틸콜린 수용체의 기능을 관찰했다. 이번 규명으로 향후 니코틴으로 인한 질병을 어느 정도 치료할 수 있을 것으로 기대 된다고 주장 하였다. 유해한 것으로만 알려진 담배의 니코틴 성분이 노인성 치매인 알츠하이머병, 파킨스병, 정신분열증에 치료 효과가 있다는 연구결과 가 나왔고 시카코 대학의 신경생물학자인 댄 머기히 박사의 최근 연구에 따르면 흡연자들 을 중독시키는 니코틴이 정신병이나 퇴행성 질병을 앓는 환자들의 두뇌 활동에 강한 충격을 주는 것으로 나타났다고 영국의 가디언지 인터넷판이 보도했다.The volatilized nicotine does not cause smoke, so there is no damage to second-hand smoke, and smokers also have 4,000 kinds of carcinogens and toxic substances included in the mainstream smoke that smokers inhale when they smoke. Because smoke is not breathed into the mouth, it may be safer from diseases such as respiratory disease, laryngeal cancer and oral cancer.The composition of volatile liquid tobacco nicotine, which is characterized by the Internet Science News Science Times, reacts in the body with nicotine, a harmful substance in tobacco The first study of the protein's mechanism reveals how nicotinic acetylcholine receptors are linked to neurotransmitter binding, which is expected to be useful in developing future therapeutics. And the mechanism The nicotinic acetylcholine receptor was identified as nicotinic because it is mainly distributed in human muscles, central nervous system, and immune cells, and it binds well with tobacco extract nicotine. Manipulation of choline receptor genes altered the structure near the ion channel and observed the function of nicotinic acetylcholine receptors. The findings suggest that it is expected to cure some nicotine-related diseases in the future. The nicotine component of tobacco, which is only known to be harmful, has therapeutic effects on Alzheimer's disease, Parkinson's disease, and schizophrenia, which is known to be harmful, and a recent study by Dr. Dan Merchi, a neurobiologist at the University of Sikako, found that Nicotine has been shown to have a strong impact on the brain activity of patients with psychotic or degenerative diseases, according to the British Guardian Internet version.
니코틴의 이런 효과 때문인지 실제로 우울증을 앓고있는 사람의 50％, 정신분열 증 환자의 95％가 담배를 피워 일반인들의 흡연율(25％)을 배 이상 능가했다. 머거히 박사는 이는 자가치료의 모습이라며 환자들은 부분적으로 정신병 치료에 도움을 주는 니코틴 때문에 담배를 피우고 있다고 주장했다.Perhaps because of these effects of nicotine, 50% of people with depression and 95% of people with schizophrenia smoke more than double the general population's smoking rate (25%). Dr. Murger argued that this is a form of self-treatment and that patients smoke because of nicotine, partly to help cure psychosis.
니코틴은 뇌의 특정 부분에 있는 세포 표면의 수용체를 자극, 쾌락의 감정과 관련된 신경전달물질 도파민을 방출하게 함으로써 사람의 중독을 유발하는 것으로 알려져 왔다. 최근 의학전문지 네이처 메디신에 흡연은 정신병리학의 표지라는 글 을 기고 한 예일대 토니 조지 박사도 니코틴이 종종 뇌세포 파괴로 나타나는 파킨스병의 진행을 느리게 한다며 머거히 박사의 주장을 지지했다. 머거히 박사는 미코틴의 치료 효과는 분명 뛰어나다면서 이번 연구는 니코틴의 추출물이 의학적으로 정신질환 완화에 도움을 줄 수도 있음을 보여준다고 말했다.Nicotine has been known to induce human addiction by stimulating receptors on the surface of cells in certain parts of the brain to release the neurotransmitter dopamine associated with pleasure emotions. Dr. Yale University's Tony George, who recently wrote in the journal Nature Medicine, said that smoking is a sign of psychopathology, he strongly supported Dr. George's claim that nicotine slows the progression of Parkinson's disease, often caused by brain cell destruction. Dr. Muerger said the therapeutic effects of nicotine are clearly excellent, and the study shows that extracts of nicotine may medically help relieve mental illness.
본 내용은 의학적인 내용이고 보다 현실적인 것은 궐련형 담배를 흡연시 발생되는 연기의 4,000가지의 유해물질이 흡연자의 호흡기로 곧바로 흡입되므로 인한 발암성물질과 독성화학물질로 인한 각종의 질병과 입안의 담배냄새, 담뱃불로 인한 화재, 주변의 담배꽁초로 인한 냄새발생, 담뱃재로인 한 주변의 지저분함 등등 많은 문제점을 동시에 해결 할 수가 있다.This is a medical content, and more realistically, 4,000 harmful substances in the smoke generated from smoking cigarettes are directly inhaled into the smoker's respiratory tract, resulting in various diseases caused by carcinogens and toxic chemicals. Many problems can be solved at the same time, such as odor, fire caused by cigarette light, odor caused by cigarette butts around, and dirty around cigarette ashes.
본 발명은 휘발성 액상담배 니코틴의 조성물에 관 한 것으로서,The present invention relates to a composition of volatile liquid tobacco nicotine,
1. 식물에서 추출한 액상의 니코틴액 (니코틴85％농도) : 30 중량부.1. Liquid nicotine liquid extracted from plants (85% nicotine concentration): 30 parts by weight.
2. 정제된 목초액 :10중량부.2. Purified wood vinegar: 10 parts by weight.
3. 감초추출물 : 5중량부.3. Licorice extract: 5 parts by weight.
4. 녹차추출물 : 20중량부.4. Green tea extract: 20 parts by weight.
5. 포도추출물 : 5중량부.5. Grape extract: 5 parts by weight.
6. 에탄올 : 20중량부.6. Ethanol: 20 parts by weight.
7. 정향추출물 : 5중량부.7. Clove extract: 5 parts by weight.
8. 박하향(멘톨) : 5중량부 (또는 초코향, 커피향, 허브향, 과일향, 한약제 향, 시가잎담배 향 )을 혼합하여 조성한 액상의 니코틴 함유 조성물로서 도면 제1 도 의 3의 용기에 4의 휘발성 액상담배 니코틴의 조성물 넣고서 도면 제1도의 2 다공성 스폰지를 도면 제1도 5의 다공성 스폰지 체결텝으로 체결하여 1의 뚜껑을 닫아서 흡연자가 흡연 하고자 할 때 도면 제1도의 1의 뚜껑을 열어서 휘발되는 냄새를 맡도록 하였다.8. Peppermint flavor (menthol): A liquid nicotine-containing composition formed by mixing 5 parts by weight (or chocolate flavor, coffee flavor, herbal flavor, fruit flavor, herbal flavor, cigar leaf tobacco flavor) in the container shown in FIG. When the composition of the volatile liquid tobacco nicotine of 4 is added and the 2 porous sponges of FIG. 1 are fastened with the porous sponge fastening step of FIG. 1, the lid 1 is closed to open the lid of FIG. 1 when the smoker wants to smoke. It was supposed to smell the volatilization.
본 발명의 실시 내용의 조성물에 대하여 상세히 설명하면 다음과 같다.Hereinafter, the composition of the embodiments of the present invention will be described in detail.
본 조성물의 니코틴의 경우 니코틴(담배알칼로이드)은 유상(油狀)의 담황색 액체로 물에 무제한으로 용해된다. 니코틴은 담배의 뿌리에서 합성되며 식물에도 함유되어있으며, 섭취하면 잠시 긴장을 풀어주고 기분을 좋게 하기도 하나 너무 많은 량을 섭취하면 해로우며 니코틴은 발암물질이 아닙니다.In the case of nicotine of the present composition, nicotine (tobacco alkaloid) is an oily pale yellow liquid, which dissolves in water indefinitely. Nicotine is synthesized in the roots of tobacco, and it is also found in plants, and when ingested, it can relax for a while and make you feel better, but it is harmful if you eat too much. Nicotine is not a carcinogen.
니코틴은 담배잎에 자생적으로 함유되는 물질로서 담배 연기의 구성 물질 가운데 하나입니다. 물론 다른 식물에도 니코틴이 함유되어 있는 경우가 있지만 담배에 비하면 훨씬 낮은 양입니다. 니코틴은 카페인과 비슷한 각성제의 역할이나 스트레스를 감소시키는 것과 같은 약리학적 역할을 하는 것으로도 잘 알려져 있으며 그 때문에 많은 보건 당국에서 니코틴이 중추 신경계에 영향을 미침으로써 담배 중독의 주요 요인으로 작용한다고 주장하고 있지만 과학적인 연구 결과를 토대로 보면 꼭 니코틴이 담배를 계속 피우게 되는 유일한 요인은 아니라고 합니다. 궐연형 담배를 흡연시에 발생되는 연기중 대부분의 발암물질은 타르로서 담배필터에 걸러지는 물과 니코틴을 뺀 나머지 물질을 통틀어 타르 이므로 각종의 질병의 요인이며, 담배의 잎담배나 담배종이가 연소하여 발생하는 일산화탄소는 담배로 인해 심장 질환이 걸리는 주요 요인으로 일산화탄소 입니다.Nicotine is a naturally occurring substance in tobacco leaves and is one of the components of tobacco smoke. Of course, other plants may also contain nicotine, but they are much lower than tobacco. Nicotine is also known to play a pharmacological role, such as a caffeine-like stimulant or to reduce stress, so many health authorities claim that nicotine acts as a major factor in tobacco addiction by affecting the central nervous system. But scientific research suggests that nicotine is not the only factor that keeps you smoking. Most of the carcinogens generated from smoking cigarettes are tar, which is a tar of all substances except nicotine and water filtered through the cigarette filter, which is a factor of various diseases. Carbon monoxide is a major cause of heart disease caused by tobacco.
본 발명의 조성물중 목초액은 참나무를 탄화시켜 탄화되는 연기를 냉각하여 액화한 물질로서 80-90％가 물과 나머지는 유기미네랄, 수분을 제외한 주성분은 초산등 화합물들로서 강한 방향성 냄새를 발생하고 있으며 1년 이상 숙성 정제하여 독성물질을 완전히 제거하여 담배의 타르 냄새가 강하여 담배의 냄새와 비슷하다. 목초액의 풍부한 초산은 살균, 해독작용이 있어 대장균 등 각종 세균을 죽이거나 염증을 예방하는 효능과 유기산은 체내에서 피로물질인 젖산을 빠르게 분해시켜 피로회복을 돕는다. 목초액의 초산과 기타의 유기산 성분이 부신피질 호르몬을 만들어 만병의 근원인 스트레스를 해소하는 작용을 한다는 연구결과이다.Wood vinegar in the composition of the present invention is a material liquefied by cooling the smoke carbonized by oak carbonized 80-90% is water and the remainder is organic minerals, except for moisture, the main component is a compound such as acetic acid, which produces a strong aromatic odor 1 Aged and refined for more than a year to remove toxic substances completely, the tar smell of tobacco is similar to the smell of tobacco. Acetic acid rich in wood vinegar has sterilization and detoxification effect, which kills various bacteria such as Escherichia coli and prevents inflammation. Acetic acid and other organic acid components of wood vinegar make corticosteroids to relieve stress, the source of all illnesses.
녹차추출물(폴리페놀 카데킨)과 포도추출물(폴리페놀 레스베라트놀)성분은 항암, 항균, 살균, 콜레스테롤 저하작용과 체내의 니코틴을 배출시키는 효능이 있다. 감초추출물은 본 발명의 조성물의 독성을 중화하고 부드러운 맛과 향을 향상 시킨다. 에탄올은 알코올의 한 종류이며 술의 주성분으로서 액화의 기화를 촉진하여 본 조성물의 휘발을 용이하게 하여준다. 본 발명의 정향추출물은 한방의 약제로서 비위를 따뜻하게 하고 곽란을 멈추게 하며, 주독을 풀어주고 향을 잘나게 한다. 박하향(멘톨) 또는 커피향, 초코향, 허브향, 과일향, 시가담배잎 추출향, 한약제 향 등은 흡연자의 기호에 따라서 선택을 할 수 있는 것에 그 특징이 있는 휘발성 액상담배 니코틴의 조성물.Green tea extract (polyphenol cadkin) and grape extract (polyphenol resveratron) have anti-cancer, antibacterial, bactericidal, cholesterol-lowering effects and the release of nicotine in the body. Licorice extract neutralizes the toxicity of the composition of the present invention and improves the soft taste and aroma. Ethanol is a kind of alcohol and as a main ingredient of alcohol, it promotes vaporization of liquefaction to facilitate volatilization of the present composition. Clove extract of the present invention as a herbal medicine to warm the stomach and stop wrecking, to relieve the poison and improve the scent. Peppermint flavor (menthol) or coffee flavor, chocolate flavor, herbal flavor, fruit flavor, cigar tobacco leaf extract, herbal flavor, etc. can be selected according to the smoker's preference, characterized in that the composition of volatile liquid tobacco nicotine.
도면 제1도 1은 본 발명의 조성물 용기뚜껑Figure 1 is a composition container lid of the present invention
도면 제1도 2는 다공성 스폰지1 is a porous sponge
도면 제 1도 3은 본 발명의 조성물 용기1 is a composition container of the present invention
도면 제1도 4는 휘발성 액상담배 니코틴의 조성물1 is a composition of volatile liquid tobacco nicotine
도면 제1도 5는 다공성 스폰지 체결 텝1 is a porous sponge fastening tab
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020080022695A KR20090097069A (en) | 2008-03-10 | 2008-03-10 | Composition of Volatile Liquid Tobacco Nicotine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020080022695A KR20090097069A (en) | 2008-03-10 | 2008-03-10 | Composition of Volatile Liquid Tobacco Nicotine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20090097069A true KR20090097069A (en) | 2009-09-15 |
Family
ID=41356580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020080022695A Ceased KR20090097069A (en) | 2008-03-10 | 2008-03-10 | Composition of Volatile Liquid Tobacco Nicotine |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20090097069A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104770863A (en) * | 2015-02-11 | 2015-07-15 | 贵州中烟工业有限责任公司 | Electronic cigarette smoke solution with herbal tea flavor |
| KR20180068236A (en) | 2016-12-13 | 2018-06-21 | 충남대학교산학협력단 | Liquid composition for eletronic cigarette and manufacture method thereof |
| KR20190028969A (en) | 2017-09-11 | 2019-03-20 | 박정하 | Composition of antismoking aid for blocking off the nicotine or tar and method for preparation using the same |
| CN109757782A (en) * | 2019-03-05 | 2019-05-17 | 铂德（深圳）科技有限公司 | Grape extract solution, grape electronics tobacco tar and preparation method thereof |
| CN109875104A (en) * | 2019-04-19 | 2019-06-14 | 云南磊然康科技有限公司 | A kind of preparation method for the electronic atomized liquid being enriched with tea aroma ingredient |
| CN111329103A (en) * | 2020-03-18 | 2020-06-26 | 福建中烟工业有限责任公司 | Electronic cigarette flavor composition, electronic cigarette liquid and their use with characteristics of Tieguanyin tea aroma |
-
2008
- 2008-03-10 KR KR1020080022695A patent/KR20090097069A/en not_active Ceased
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104770863A (en) * | 2015-02-11 | 2015-07-15 | 贵州中烟工业有限责任公司 | Electronic cigarette smoke solution with herbal tea flavor |
| KR20180068236A (en) | 2016-12-13 | 2018-06-21 | 충남대학교산학협력단 | Liquid composition for eletronic cigarette and manufacture method thereof |
| KR20190028969A (en) | 2017-09-11 | 2019-03-20 | 박정하 | Composition of antismoking aid for blocking off the nicotine or tar and method for preparation using the same |
| CN109757782A (en) * | 2019-03-05 | 2019-05-17 | 铂德（深圳）科技有限公司 | Grape extract solution, grape electronics tobacco tar and preparation method thereof |
| CN109875104A (en) * | 2019-04-19 | 2019-06-14 | 云南磊然康科技有限公司 | A kind of preparation method for the electronic atomized liquid being enriched with tea aroma ingredient |
| CN111329103A (en) * | 2020-03-18 | 2020-06-26 | 福建中烟工业有限责任公司 | Electronic cigarette flavor composition, electronic cigarette liquid and their use with characteristics of Tieguanyin tea aroma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2790536B1 (en) | Device and method for simulating chemosensation of smoking | |
| Haustein et al. | Tobacco or health?: physiological and social damages caused by tobacco smoking | |
| JP3939363B2 (en) | Health cigarette | |
| ES2706740T3 (en) | Substitute of tobacco | |
| CN100506241C (en) | Smoking cessation healthcare product and preparation method thereof | |
| RU72821U1 (en) | SMOKLESS SMOKING PRODUCT (OPTIONS) | |
| JP2017501714A (en) | Liquid composition for electronic cigarette | |
| WO2006097447A1 (en) | Combined use of herbal cigarettes and nicotine replacement therapy | |
| KR20090097069A (en) | Composition of Volatile Liquid Tobacco Nicotine | |
| EP0148749A2 (en) | Nicotine preparation | |
| Sakthisankaran et al. | Health Risks Associated with Tobacco Consumption in Humans: An Overview. | |
| LU100976B1 (en) | New tobacco substitutes | |
| KR200412339Y1 (en) | Low nicotine tobacco | |
| US20030131857A1 (en) | Nicotine free cigarette substitute | |
| JP3691021B2 (en) | Cigarette filters and cigarettes | |
| CN103040103B (en) | Fennel type snuff | |
| JP2004229627A (en) | Tobacco substitute inhaled through nose | |
| KR20130080414A (en) | Composition of smoke-free volatile herbal extract | |
| CN1470279A (en) | Detoxifying and smoking-stopping cigarette, and its preparing method and use | |
| CN103040106B (en) | Orange scent type snuffing tobacco | |
| WO2025062812A1 (en) | Liquid composition and electronic cigarette | |
| WO2025099687A1 (en) | Liquid composition for e-cigarette and e-cigarette containing such composition | |
| CN103040099B (en) | Clove type snuff | |
| Dixon | THE TWELFTH NORMAN KERR MEMORIAL LECTURE: 1927.* THE TOBACCO HABIT | |
| Shetty et al. | TOBACCO DE-ADDICTION. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20080310 |
|
| PA0201 | Request for examination | ||
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20100222 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20100705 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20100222 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |